Waters Stock Price, News & Analysis

Waters Corporation (NYSE:WAT) has acquired technology assets and intellectual property from Megadalton Solutions, enhancing its capabilities in Charge Detection Mass Spectrometry (CDMS). This acquisition allows Waters to overcome the limitations of traditional mass spectrometry, particularly in analyzing large proteins used in cell and gene therapies. The integration of CDMS technology is expected to expand Waters' product offerings and attract new customers in the biopharmaceutical sector, potentially boosting revenue from next-generation biologics.

Waters Corporation (NYSE: WAT) reported fourth quarter 2021 sales of $836 million, an increase of 6% as reported and 8% in constant currency from $787 million in Q4 2020. GAAP EPS rose to $3.52 from $3.49. Full-year sales reached $2,786 million, an 18% increase, with GAAP EPS at $11.17, up from $8.36. Despite ongoing pandemic challenges, strong growth was seen across biopharma and industrial sectors. The company expects 2022 sales growth of 5% to 7% and non-GAAP EPS of $11.75 to $12.00.

Waters Corporation (NYSE: WAT) announced that the U.S. FDA has expanded its use of Waters' Empower Chromatography Data Software and added NuGenesis Laboratory Management Software to support pharmaceutical testing. This transition to a common data management platform across five labs will enhance data retrieval and compliance with legislative mandates. Both software solutions will improve operational efficiencies for the FDA, allowing better management of analytical data vital for public health and safety.

Waters Corporation (NYSE:WAT) will live webcast its Q4 2021 financial results conference call on February 1, 2022, at 8:00 a.m. ET. Investors can access the presentation via Waters’ investor relations website. A replay will be available until February 15, 2022, at midnight ET. Waters, a leader in specialty measurement, has over 7,400 employees globally and operates in 35 countries, emphasizing innovations in chromatography and mass spectrometry.

Waters Corporation (NYSE:WAT) has expanded its waters_connect informatics platform to support tandem quadrupole mass spectrometers with the new MS Quan application. This software enhances quantitative analysis by cutting data review time by up to 50% and facilitating compliance and data integrity. It streamlines the processing of large sample sets and enables accurate results in a secure manner. The MS Quan app is now globally available as an upgrade for select Waters' mass spectrometers, aiding laboratories in analyzing food and environmental samples effectively.

Waters Corporation (NYSE:WAT) will present at the J.P. Morgan Healthcare Conference on January 10, 2022, at 8:15 AM EST. Udit Batra, Ph.D., President and CEO, will address the investment community virtually. Interested investors can access the live webcast through Waters’ investor relations website, with a replay available for 30 days. Waters has led innovations in chromatography and mass spectrometry for over 60 years, operating in 35 countries and employing over 7,400 individuals worldwide.

Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D., President and CEO, will present at the Evercore ISI 4th Annual HealthCONx Healthcare Conference on November 30, 2021, at 12:10 PM EST. Investors can access the live webcast on the company's investor relations website, with a replay available for 90 days. Founded over 60 years ago, Waters is a leader in specialty measurement, including chromatography and mass spectrometry, with operations in 35 countries and products available in over 100 countries.